TETRALYSAL Hard capsule Ref.[27953] Active ingredients:

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2020  Publisher: Galderma (UK) Limited, Meridien House, 69-71 Clarendon Road, Watford, Herts., WD17 1DS, UK

Product name and form

Tetralysal 300 mg Hard Capsules.

Pharmaceutical Form

Hard capsule.

Hard gelatin capsule, red cap and yellow body.

Qualitative and quantitative composition

Each capsule contains 408 mg of Lymecycline equivalent to 300 mg tetracycline base.

For the full list of excipients, see section 6.1.

List of Excipients

Magnesium stearate
Colloidal hydrated silica

The capsule shells contain:

Gelatin
Titanium dioxide (E171)
Erythrosine (E127)
Quinoline yellow (E104)
Indigotine (E132)

Pack sizes and marketing

Aluminium-PVC/PVDC calendar blister strips of 14 capsules; two strips per carton, pack size = 28 capsules or Aluminium and polyethylene strips 28 or 56 capsule pack size.

Not all pack sizes may be marketed.

Marketing authorization holder

Galderma (UK) Limited, Meridien House, 69-71 Clarendon Road, Watford, Herts., WD17 1DS, UK

Marketing authorization dates and numbers

PL 10590/0019

29th September 1995

Drugs

Drug Countries
TETRALYSAL Brazil, Ecuador, Finland, France, Hong Kong, Ireland, Malta, New Zealand, Poland, Tunisia, United Kingdom, South Africa
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈